Hello Inside’s Post

That´s it! The news is out! Hello Inside raised €1.65m in Seed. We are excited to continue our mission of supporting women in their metabolic health journeys! Before saying a 𝐡𝐞𝐚𝐫𝐭𝐟𝐞𝐥𝐭 𝐭𝐡𝐚𝐧𝐤 𝐲𝐨𝐮 to our always supportive existing investors & new investors at Verge HealthTech Fund, DocMorris & KAPA Ventures, I wanted to share some thoughts on FemTech. Despite early feedback from our users, medical advisors, and angel investors to set the focus on women’s health right away, we were reluctant to do so. Why? Maybe because of the 𝐠𝐞𝐧𝐞𝐫𝐚𝐥 𝐬𝐭𝐢𝐠𝐦𝐚 topics like PMS, Menopause, PCOS, Sexual health, etc. still have. Maybe because of the 𝐬𝐭𝐢𝐥𝐥 𝐞𝐱𝐢𝐬𝐭𝐢𝐧𝐠 𝐤𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞 𝐚𝐧𝐝 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐠𝐚𝐩𝐬 - persistent with experts, doctors, and institutions making it tough for a consumer startup to establish a business. Maybe because as a man 𝐲𝐨𝐮 𝐬𝐨𝐦𝐞𝐭𝐢𝐦𝐞𝐬 𝐟𝐞𝐞𝐥 𝐥𝐢𝐤𝐞 𝐚 𝐟𝐫𝐚𝐮𝐝 talking about Women’s Health. But I am glad we have the means and understanding to take concern in the health of our mothers, sisters, aunts friends, and family. Let’s all be voices of support in that process. We are certain that we are on the right path, fully understanding the huge opportunity in this $ 𝟒𝟒 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 and are confident in our mission. Our users love the App and the measurable health results it delivers for them. An 𝐍𝐏𝐒 𝐨𝐟 𝟒𝟔 & an average of 𝟏𝟎 𝐀𝐩𝐩𝐎𝐩𝐞𝐧𝐬 𝐩𝐞𝐫 𝐝𝐚𝐲/𝐮𝐬𝐞𝐫 shows unprecedented engagement in the Health & Wellness category. In that spirit, let’s build this next chapter of Hello Inside! Scarlett, Ed Deng, Miguel, David Masó, Christoph, Anja Gottschalk-Wenk, Frank Kappe, Jürgen Furian, Vinzenz Weber, Dr. Anne Latz, Martin Kamleithner, Daniela Schwaiger, Marie-Luise Huber

Here at S2S Ventures, we support early-stage startups in becoming VC-ready and kickstart their fundraising journeys! 🪂 A significant part of our investment process consists in conducting thorough due diligence as an independent student-run venture capital fund. This due diligence takes form as an investment memo, which we can then share with our network as well as other investor leads. This is one of the unique aspects of S2S Ventures that provides significant value and feedback to startup founders. It also establishes trust and accelerates the due diligence of other potential investors! Today, we’re thrilled to publish a short public investment memo written by our partner David Campbell about one of our latest portfolio companies Maven Health. This piece goes over the reasons why S2S Ventures is such a strong supporter of Maven Health, and why we believe they are uniquely positioned to improve preventive metabolic healthcare at large. 👉 Go read our memo here: https://lnkd.in/gtUUTDzx Go team Kevin Hof, Christopher Wall, Alexandre Aubert 🙌

Recently we announced that Maven Health is to partner with S2S Venture. Check out the insightful article by S2S Ventures as to why they see our approach as a winning formula. [Link to the Medium article in the message below]

ETHIAS VENTURES PORTFOLIO UPDATE : moveUP - digital therapies   👨⚕️📱 moveUP offers a digital health platform that offers personalized guidance and support. By incorporating remote monitoring and tailored interventions, moveUP helps individuals manage musculoskeletal issues and chronic conditions more effectively, thereby reducing complications and readmissions. This cost-saving solution revolutionizes rehabilitation practices and enhances patient outcomes. 🚶♂️ moveUP, founded in 2015, began with a focus on rehabilitating hip and knee arthroplasty patients but has expanded to support individuals with diverse musculoskeletal (MSK) and chronic conditions. It also facilitates healthcare professionals (HCPs) in making data-driven decisions and gaining insights. With a presence in numerous countries across Europe, the US, and Australia, moveUP has emerged as a comprehensive solution for improving patient care and empowering healthcare providers.   📈 Ethias Ventures invested in 2023 in moveUP to accelerate the expansion of its innovative health platform for its domestic and international markets.   🚀 Moving forward, moveUP plans to extend its solution to support patients on a broader scale worldwide. Having successfully served over 10.000 satisfied patients, moveUP is motivated to continue its mission of providing practical and impactful care solutions globally.   👉 Want to know more about moveUP - digital therapies? Follow moveUP on Linkedin: https://lnkd.in/ebbRMjuE   👉 Are you a startup in #healthcare raising fund soon? Contact Ethias Ventures at ventures@ethias.be Charles-Eric Winandy Ward Servaes Bob Moens Ciaran G McCourt #ethiasventures #cvc #moveup #digitalmedtech #healthinnovation

𝗙𝗩𝗖 𝗜𝗡𝗩𝗘𝗦𝗧𝗦 𝗜𝗡𝗧𝗢 𝗗𝗘𝗘𝗣𝗧𝗘𝗖𝗛 / 𝗕𝗜𝗢𝗠𝗘𝗗𝗧𝗘𝗖𝗛 𝗧𝗢 𝗘𝗡𝗔𝗕𝗟𝗘 𝗔𝗟𝗟 𝗧𝗢 𝗕𝗥𝗘𝗔𝗧𝗛𝗘 𝗘𝗔𝗦𝗜𝗘𝗥 𝗜𝗡 𝗔 𝗚𝗥𝗘𝗘𝗡 𝗙𝗨𝗧𝗨𝗥𝗘 The Stethoscope - it's a quintessential symbol of the medical profession (since its advent in 1816), due to the all-important functions of monitoring the health of internal organs such as the heart, bowels, and the lungs. And the importance of lung health (and breathing well!) was front and centre of everyones' lives during the recent global pandemic. 👀 There's also an urgent need to improve respiratory diagnostics/monitoring, especially for community/remote health settings and other health conditions (where repeated measurements are needed). We reckon, that #AeviceHealth is the key to greater lung health in the digital age. Farquhar VC (FVC) is privileged to participate in the latest Seed-Plus round of Aevice Health (led by cofounders Adrian Ang and Rex X. Tan), where we invested alongside Coronet Ventures (led by Nirdesh K Gupta, PhD and Colin Tan), the venture affiliate of Cedars-Sinai. Other key investors include East Ventures (a juggernaut in Indonesia!), A&D Company (a world leader in #precision measurement equipment), and SEEDS Capital (the investment arm of Enterprise Singapore). Congrats Adrian, Rex, Karen, and the team. Special shoutout to The Business Times' Hykel Quek for being among the first to report on the happy news! https://lnkd.in/gFfnhS94 𝙄𝙣𝙩𝙚𝙧𝙚𝙨𝙩𝙞𝙣𝙜 𝙨𝙞𝙙𝙚𝙛𝙖𝙘𝙩:  (as a FVC portfolio startup), Aevice is... - our 𝟭𝘀𝘁 startup that's also a portfolio of NTUitive (led by CEO David Toh) - our 𝟮𝗻𝗱 startup that's also a A*STAR - Agency for Science, Technology and Research #deeptech spinoff (we're blessed to be neighbours and friends of A*StartCentral!);  - our 𝟯𝗿𝗱 startup that we have the honour of sharing the captable with SEEDS Capital; - our 𝟰𝘁𝗵 startup that has undergone #acceleration in North Asia via the Ministry of SMEs and Startups, Republic of Korea - KISED (Korea Institute of Startup & Entrepreneurship Development) K-Startup Grand Challenge ; - our 𝟱𝘁𝗵 startup that we've coinvested alongside with East Ventures (led by Pak Willson Cuaca)

💰 Hello Inside, a startup focused on improving metabolic health for women through continuous glucose monitoring (CGM) technology, has secured €1.65 million in seed funding. This funding round was led by Verge Fund, a healthtech venture capital firm, with additional support from DocMorris, Germany's leading online pharmacy, and KAPA VENTURES LLC. 💸 💬 "Attention is the key to behavior change and positive health impact. By pairing this with the power of AI and the knowledge of our medical experts, we can offer women a profound understanding of their metabolic health. Our technology is not just about tracking data, but about providing actionable insights that lead to meaningful changes in health and wellness." Hello Inside Co-founder & CEO Mario Aichlseder #health #heatlhtech #digitalhealth #femtech #womenshealth #womenshealthinnovation #healthcare #cgm #continousglucosemonitoring #metabolichealth #femhealth #investment #startup #seedround #vc #venturecapital

🎉 Celebrating 5 years of Crista Galli Ventures 🎉 In 2017 as an MBA-wielding consultant (attending) radiologist for the NHS in London, I saw ever-increasing demand for scans outstripping the global supply of radiologists. I knew that tech was needed to take healthcare into its next frontier & I wanted to be part of that change. 👩🏽⚕️ In 2018, I quit the NHS & started angel investing. As a radiologist, I added an expert medical lens to the various healthtech startups I met. In April 2019, I founded Crista Galli Ventures, my healthtech fund. 💸 Crista Galli Ventures is the healthtech arm of IPQ Capital, the Family Office of our Fryland Møller Pathiraja family. We don’t take external capital and only invest our own family’s capital. This means we are agile investors, able to operate without the layers of bureaucracy of a traditional fund. We know healthcare & invest for the very long-term. 🤖 5 years later, deep tech remains my personal favourite investment area. The things I dreamt of as the future of radiology in 2017 are now reality! These include GLEAMER, reading bone age x-rays, which took absolutely AGES to do as a young radiologist, or Subtle Medical, improving image quality on an MRI scan as the patient moved too much, or Quibim reading a prostate cancer scan on a very long prostate MRI list. ✨ If you dream something, with enough grit & tenacity, you can bring it to life. Crista Galli Ventures was once a seed idea at London Business School. Today, we are bringing the future to life in healthcare. And you know what, THE FUTURE IS NOW. Here’s to the next 5 years 🥂 #femaleinvestor #healthtech #LondonBusinessSchool #Investing #Medicine #Doctor

Imagine you are a start-up founder and decide to make the largest capital investment in a packing machine to speed up the production process and achieve scale. Then imagine that you start growing 20% month-over-month for 7 months straight and move to the US to launch on that market, simultaneously raising the first venture investment. Is it a good feeling? Now, let's have a reality check. Imagine that the machine, still under warranty and insured, starts malfunctioning and that the supplier is not interested in solving the situation swiftly. Imagine that the malfunctioning is not immediately visible, but that the packing starts leaking after two weeks when delivered to clients. Imagine Sisyphus's efforts for sales and fundraising in the US while that is happening. Imagine finding yourself without revenue for the first time in 4 years with all the ongoing costs, including ML development, US entry, scientific research, leases, and the team. Imagine trying to find a contracting facility and not being able to get an appointment anytime soon. Imagine the ridicule, skepticism, and doubts. Both from others and, even stronger, from yourself. Is it still a good feeling? Now, wait - the white towel is still in the corner. Imagine having angel investors who are willing to support you despite their kitchen having traces of leaked AgeBiotics. Imagine having 90% of the clients not churning and staying for four months without shipments, with dozens of supportive messages. Imagine finally being able to pack the new batch of AgeBiotics, with the best organoleptics and opening ever. Imagine re-launching with three new AgeBiotics formulas, a new website, new app, and new hope. That is what happened today. Link in the comment. Thank you for supporting the dream of applied science - enhanced cognitive flexibility, emotional resilience, and biological longevity - the dream Ani is turning into reality. Is it a good feeling? It does not matter, because it is worthwhile. Ani Biome is still accepting angel investments, DM if interested. #startuplife #plans #mentalhealth #guthealth #longevity #personalizednutrition #biotech Nika Pintar Iva Hlapčić

"🎉 Big news! Aware Health has secured $3M in seed funding led by Boomerang Ventures to expand value-based musculoskeletal solutions.⚕️ 💡 CEO Heidi Ojha says, 'We are using the funds to build out our AI models, a new patient and provider engagement platform, and comprehensive employer dashboards to expand our reach and impact in helping more people get the care they need.' 🚀 And Oscar Moralez from Boomerang Ventures adds, 'Aware Health is uniquely positioned to disrupt the healthcare system with its direct-to-employer model and innovative approach to musculoskeletal care. This investment marks a significant milestone for Boomerang Ventures as we expand our portfolio beyond 'middle America' and reinforce our commitment to supporting women-led companies.'  💪 Joining Boomerang Ventures in this seed round were Bright Ventures, Suncoast Ventures, Tidal River Women's Investor Group, Impulsum Venture Colab, Techstars, and pivotal angel investors, including Paul Johnson 🇬🇧🇺🇸, ex-CEO and founder of Lemonaid Health, and Sachin Bhat, former co-founder of Scribe and prior Head of Engineering at Rippling. Learn more about how Aware Health is helping reduce unnecessary surgeries and saving millions in healthcare costs. 🔗 Read the full press release: https://shorturl.at/fadQ5 #MSKcare #HealthTech #TeleRehab #DigitalHealth #HealthcareInnovation #SurgeryPrevention #AIinHealthcare #Startups #VentureCapital #WomenInTech #HealthManagement #HealthcareTransformation #AIHealthcare #BoomerangVentures #AwareHealth #BrightVentures #SuncoastVentures #TidalRiverFund #ImpulsumVentures #Techstars

Lifetime Health, a digital platform for at-home care, has raised $1.5 million in a seed funding round led by US-based venture capital firm The Garage Syndicate, along with participation from other angel investors. 🌟 Key Highlights: The company earlier secured $900,000 in its last round from an existing investor. As per the startup, the funding will be used to deploy towards further development. About Lifetime Health: Co-founded by Konstantin Riabtsev, Michail Vorobiev and Nabil Ahmed in 2023, Lifetime Health is a digital platform for hospital-at-home care providing phlebotomy services, diagnostic tools, medical devices, nursing care, physiotherapy, and postoperative care all in one app. Its automated platform makes sure that it is fast, high-quality, and affordable service, from the client’s order to the nurse’s departure and results processing. Visit the link to read the detailed news piece: https://lnkd.in/gQnhV94i #startup #funding #news #startupfunding #latestnews #news #lifetimehealth #health #lifetime